$0.31
+0.02 (+6.21%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where CWBHF is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 observational
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Full Spectrum Hemp Observational StudyNCT04730414observationalFacial Blemishes | — | Unknown status | Drug: Full-spectrum hemp (0.018% THC) | Acne Vulgaris, Acne Vulgaris Superficial Mixed Comedonal and Inflammatory | 50 | Dec 2021 | 2021-02-01 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19